Similar articles for PMID: 20360136

Year	Number of Results
2002	3
2003	1
2004	1
2005	5
2006	6
2007	4
2008	11
2009	14
2010	10
2011	12
2012	8
2013	9
2014	8
2015	8
2016	10
2017	5
2018	6
2019	7
2020	8
2021	4
2022	5
2024	0

1

Discontinuation of infliximab after attaining low disease activity in patients with rheumatoid arthritis: RRR (remission induction by Remicade in RA) study.

Tanaka Y, Takeuchi T, Mimori T, Saito K, Nawata M, Kameda H, Nojima T, Miyasaka N, Koike T; RRR study investigators. Tanaka Y, et al. Ann Rheum Dis. 2010 Jul;69(7):1286-91. doi: 10.1136/ard.2009.121491. Epub 2010 Apr 1. Ann Rheum Dis. 2010. PMID: 20360136 Free PMC article.

2

Discontinuation of infliximab in rheumatoid arthritis patients in clinical remission.

Nawata M, Saito K, Nakayamada S, Tanaka Y. Nawata M, et al. Mod Rheumatol. 2008;18(5):460-4. doi: 10.1007/s10165-008-0089-1. Epub 2008 Jun 6. Mod Rheumatol. 2008. PMID: 18535759 Clinical Trial.

3

Association of the multi-biomarker disease activity score with joint destruction in patients with rheumatoid arthritis receiving tumor necrosis factor-alpha inhibitor treatment in clinical practice.

Hirata S, Li W, Kubo S, Fukuyo S, Mizuno Y, Hanami K, Sawamukai N, Yamaoka K, Saito K, Defranoux NA, Tanaka Y. Hirata S, et al. Mod Rheumatol. 2016 Nov;26(6):850-856. doi: 10.3109/14397595.2016.1153449. Epub 2016 Mar 30. Mod Rheumatol. 2016. PMID: 26873570

4

Which factors influence radiographic progression during treatment with tumor necrosis factor inhibitors in clinical practice? Results from 930 patients with rheumatoid arthritis in the nationwide Danish DANBIO registry.

Ørnbjerg LM, Østergaard M, Bøyesen P, Krogh NS, Thormann A, Tarp U, Poulsen UE, Espesen J, Schlemmer A, Graudal N, Kollerup G, Jensen DV, Madsen OR, Glintborg B, Christensen T, Lindegaard H, Bøhme W, Hansen A, Andersen AR, Hetland ML. Ørnbjerg LM, et al. J Rheumatol. 2014 Dec;41(12):2352-60. doi: 10.3899/jrheum.131299. Epub 2014 Oct 1. J Rheumatol. 2014. PMID: 25274894

5

Seven-year follow-up of infliximab therapy in rheumatoid arthritis patients with severe long-standing refractory disease: attrition rate and evolution of disease activity.

Vander Cruyssen B, Durez P, Westhovens R, De Keyser F. Vander Cruyssen B, et al. Arthritis Res Ther. 2010;12(3):R77. doi: 10.1186/ar2997. Epub 2010 May 6. Arthritis Res Ther. 2010. PMID: 20459619 Free PMC article.

6

Radiographic changes in rheumatoid arthritis patients attaining different disease activity states with methotrexate monotherapy and infliximab plus methotrexate: the impacts of remission and tumour necrosis factor blockade.

Smolen JS, Han C, van der Heijde DM, Emery P, Bathon JM, Keystone E, Maini RN, Kalden JR, Aletaha D, Baker D, Han J, Bala M, St Clair EW; Active-Controlled Study of Patients Receiving Infliximab for the Treatment of Rheumatoid Arthritis of Early Onset (ASPIRE) Study Group. Smolen JS, et al. Ann Rheum Dis. 2009 Jun;68(6):823-7. doi: 10.1136/ard.2008.090019. Epub 2008 Jul 1. Ann Rheum Dis. 2009. PMID: 18593759 Clinical Trial.

7

Two-year Outcomes of Infliximab Discontinuation in Patients with Rheumatoid Arthritis: A Retrospective Analysis from a Single Center.

Takai C, Ito S, Kobayashi D, Nemoto T, Lee H, Abe A, Otani H, Nakazono K, Murasawa A, Ishikawa H. Takai C, et al. Intern Med. 2020;59(16):1963-1970. doi: 10.2169/internalmedicine.3934-19. Epub 2020 Aug 15. Intern Med. 2020. PMID: 32801270 Free PMC article.

8

Discontinuation of adalimumab after attaining disease activity score 28-erythrocyte sedimentation rate remission in patients with rheumatoid arthritis (HONOR study): an observational study.

Hirata S, Saito K, Kubo S, Fukuyo S, Mizuno Y, Iwata S, Nawata M, Sawamukai N, Nakano K, Yamaoka K, Tanaka Y. Hirata S, et al. Arthritis Res Ther. 2013 Sep 25;15(5):R135. doi: 10.1186/ar4315. Arthritis Res Ther. 2013. PMID: 24286472 Free PMC article.

9

Clinical impact of switching from infliximab to etanercept in patients with rheumatoid arthritis.

Laas K, Peltomaa R, Kautiainen H, Leirisalo-Repo M. Laas K, et al. Clin Rheumatol. 2008 Jul;27(7):927-32. doi: 10.1007/s10067-008-0880-6. Epub 2008 Apr 15. Clin Rheumatol. 2008. PMID: 18414967

10

Structural and functional outcomes of a therapeutic strategy targeting low disease activity in patients with elderly-onset rheumatoid arthritis: a prospective cohort study (CRANE).

Sugihara T, Ishizaki T, Hosoya T, Iga S, Yokoyama W, Hirano F, Miyasaka N, Harigai M. Sugihara T, et al. Rheumatology (Oxford). 2015 May;54(5):798-807. doi: 10.1093/rheumatology/keu395. Epub 2014 Oct 8. Rheumatology (Oxford). 2015. PMID: 25296748

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

119 results

Results by year